Tamil Nadu has stepped up efforts to deepen its presence in the global life sciences sector, representing India at Swiss Biotech Day this week — a key industry event in one of the world’s most advanced life sciences ecosystems.
The delegation, led by state investment promotion agency Guidance Tamil Nadu, held discussions with leading stakeholders across biotechnology, pharmaceuticals and medtech, aiming to position the state as a competitive destination for investment and innovation.
The visit follows the state's announcement in the 2025–26 budget to establish a bioscience park near Chennai, aimed at bolstering its position in the fields of biosimilars and therapeutics, according to sources from Guidance
The visit also comes shortly after the signing of the India–EFTA Trade and Economic Partnership Agreement (TEPA), a landmark deal with the European Free Trade Association comprising Switzerland, Norway, Iceland and Liechtenstein. The agreement is expected to facilitate greater market access and regulatory alignment across high-value sectors, Guidance stated in a social media post.
As one of India’s top exporting states with a diversified industrial base, Tamil Nadu is looking to leverage the trade pact to integrate more deeply into global value chains and attract investment from advanced economies. The state sees significant potential to expand its footprint in high-tech manufacturing and life sciences, tapping into Swiss expertise and capital.
The state has previously attracted major global players across the automotive and electronics sectors, and is now seeking to replicate that success in biotechnology and advanced manufacturing.
No comments:
Post a Comment